🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

23 recruiting trials

for Tuberous Sclerosis Complex (TSC)

Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants NCT04987463Phase 2, Phase 32 sites📍 Warsaw📍 Warsaw Katarzyna Kotulska · Tests: Vigabatrin, Rapamycin, Placebo, Placebo Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders NCT06081348Phase 27 sites📍 Calgary📍 Edmonton📍 Halifax Holland Bloorview Kids Rehabilitation Hospital · Tests: Sertraline, Placebo TSC Biosample Repository and Natural History Database NCT05676099n/a26 sites📍 Birmingham📍 Loma Linda📍 Los Angeles National Tuberous Sclerosis Association · Tests: Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure GROWing Up With Rare GENEtic Syndromes NCT04463316n/a1 site📍 Rotterdam dr. Laura C. G. de Graaff-Herder · Tests: Retrospective file studies Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Study of Skin Tumors in Tuberous Sclerosis NCT00001975n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling NCT06330350n/a1 site📍 Maastricht Maastricht University Medical Center · Tests: Qualitative interview Study of the Disease Process of Lymphangioleiomyomatosis NCT00001465n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: Toshibia Aquilion One CT A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines NCT07561957NA2 sites📍 Dublin📍 Dublin St. James's Hospital, Ireland · Tests: Use of an electronic digital Application Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis NCT06764602n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients NCT06523582n/a3 sites📍 Mexico City📍 Mexico City📍 Mexico City Universidad Nacional Autonoma de Mexico Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study NCT05104983Phase 211 sites📍 Birmingham📍 Los Angeles📍 Palo Alto Darcy Krueger · Tests: Sirolimus, Placebo Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex NCT07304856n/a1 site📍 Milan University of Milan · Tests: Pulmonary Function Test, Analysis of Extracellular Vesicles Regulating Together in Tuberous Sclerosis Complex NCT06105736NA2 sites📍 Carrboro📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Behavioral Intervention in a small group platform Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies NCT02890641n/a1 site📍 Paris Fondation Ophtalmologique Adolphe de Rothschild · Tests: Sampling of blood, frozen resected tissues, and cerebrospinal fluid (CSF) Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME) NCT07287202Phase 1, Phase 22 sites📍 Heidelberg📍 Melbourne Sovargen · Tests: SVG103 Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC) NCT07403266Phase 31 site📍 Madrid Oils4Cure · Tests: YCJ-01 Full Spectrum cannbis Extract, Placebo Role of Genetic Factors in the Development of Lung Disease NCT00001532n/a2 sites📍 Bethesda📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex NCT05534672Phase 32 sites📍 Lodz📍 Warsaw Katarzyna Kotulska · Tests: Rapamycin, Placebo Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) NCT07575347n/a1 site📍 Bucharest Stefan Lujinschi · Tests: Observational assessment National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry) NCT06160310n/a1 site📍 Cincinnati David M. Ritter
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy